Inactive Instrument

Press Releases Science 37 Holdings, Inc.

Equities

SNCE

US8086442071

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

EMed completes tender offer for all outstanding shares of Science 37	Mar. 12	PR
SCIENCE 37 HOLDINGS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Science 37 Holdings, Inc. - SNCE	Feb. 27	BU
SCIENCE 37 HOLDINGS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Science 37 Holdings, Inc. - SNCE	Feb. 10	BU
INVESTIGATION ALERT: Halper Sadeh LLC Investigates MGRC, SNCE, VINE, CALB	Feb. 06	PR
Shareholder Alert: Ademi LLP investigates whether Science 37 Holdings, Inc. has obtained a Fair Price in its transaction with eMed	Jan. 31	PR
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates MGRC, SNCE, VINE, CERE	Jan. 29	PR
SNCE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Science 37 Holdings, Inc. Is Fair to Shareholders	Jan. 29	BU
Science 37 to be Acquired by eMed, Expanding Access to Patients and Accelerating Enrollment	Jan. 29	AQ
Science 37 : Citeline Connect Partners with Science 37	Dec. 15	PU
Science 37 Receives Top Honors in Everest PEAK Matrix®	Dec. 12	AQ
Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)	Dec. 07	GL
Science 37 Holdings, Inc. Announces 1-for-20 Reverse Stock Split effective December 8, 2023	Dec. 05	GL
Science 37 Holdings, Inc. Announces 1-for-20 Reverse Stock Split effective December 8, 2023	Dec. 05	AQ
Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)	Nov. 10	GL
Science 37 Reports Third Quarter 2023 Financial Results	Nov. 07	GL
Science 37 to Report Third Quarter 2023 Financial Results on November 7, 2023	23-10-24	GL
Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)	23-10-06	GL
Science 37 Chief Delivery Officer, Darcy Forman, Named to Prestigious PharmaVoice 100 List	23-09-20	GL
Science 37 Chief Delivery Officer, Darcy Forman, Named to Prestigious PharmaVoice 100 List	23-09-20	AQ
Science 37 Recognized in the Gartner® Hype Cycle™ for Life Science Clinical Development, 2023	23-09-13	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Science 37 Holdings, Inc.

Equities

SNCE

US8086442071

Press Releases

Filters